15289-s-bos

6 95 | Lp(a) is not associated with carotid plaques and C-IMT in FH Conclusion In statin-treated FH patients, we cannot prove that Lp(a) is a residual risk factor of CVD, since Lp(a) levels are not associated with the presence of carotid plaque presence and the C-IMT. This is most likely explained by the long-term adequate statin treatment resulting in a lowC-IMT, and the relative lowprevalence of plaques in the carotid arteries.